Matches in SemOpenAlex for { <https://semopenalex.org/work/W4297788159> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- W4297788159 abstract "Abstract. Floating sustained release tablets were developed to increase the elimination half-life and bioavailability of the drug because it is able to release the active substance for a long duration by a floating mechanism in gastric fluid. This study aims to examine the development of floating tablets for the purpose of sustained release in terms of formulation and manufacturing methods, as well as the effect of developing floating sustained release tablets on pharmacokinetic parameters. The research method used is a systematic literature review by searching for international articles from reputable publishers. The results showed that floating sustained release tablet preparations had been developed for active substances such as alfuzosin HCl, baclofen, cephalexin, famotidine, imanitib mesylate, meberevine HCl, metformin HCl, and troxipide which had met the requirements of a good preparation, namely having a floating lag time in the range 5-600 seconds and a floating duration time of more than 12 hours. The most widely used manufacturing method is the effervescent with the addition of polymer and the presence of an effervescent , namely the reaction between sodium bicarbonate and organic acids (citric acid or tartaric acid). Floating sustained release tablets were able to increase the value of pharmacokinetic parameters such as t1/2, tmax and increase AUC in the range of 2.74-133.8%. 
 Abstrak. Sediaan floating sustained release tablet dikembangkan untuk meningkatkan waktu paruh eliminasi dan ketersediaan hayati obat karena mampu melepaskan zat aktif dalam durasi yang panjang dengan mekanisme mengapung di dalam cairan lambung. Penelitian ini bertujuan untuk mengkaji pengembangan sediaan floating tablet untuk tujuan sustained release dalam hal formulasi dan metode pembuatan, serta pengaruh pengembangan sediaan floating sustained release tablet terhadap parameter farmakokinetik. Metode penelitian yang digunakan yaitu systematic literatur review dengan cara mencari artikel internasional dari penerbit bereputasi. Hasil penelitian ini menunjukan bahwa sediaan floating sustained release tablet sudah dikembangkan untuk zat aktif seperti alfuzosin HCl, baclofen, cephalexin, famotidine, imanitib mesylate, meberevine HCl, metformin HCl, dan troxipide yang dimana telah memuhi persyaratan sediaan baik yaitu memiliki nilai floating lag time dalam rentang 5-600 detik dan floating duration time lebih dari 12 jam. Metode pembuatan yang paling banyak digunakan yaitu metode effervescent dengan penambahan polimer serta adanya agen effervescent yaitu reaksi antara natrium bikarbonat dengan asam organik (asam sistrat atau asam tartarat). Sediaan floating sustained release tablet mampu meningkatan nilai parameter farmakokinetik seperti t1/2, tmax dan peningkatan AUC dalam rentang 2,74-133,8 %." @default.
- W4297788159 created "2022-10-01" @default.
- W4297788159 creator A5008291067 @default.
- W4297788159 creator A5080187441 @default.
- W4297788159 creator A5087003916 @default.
- W4297788159 date "2022-07-28" @default.
- W4297788159 modified "2023-10-18" @default.
- W4297788159 title "Kajian Pengembangan Sediaan Floating Sustained Release Tablet" @default.
- W4297788159 doi "https://doi.org/10.29313/bcsp.v2i2.3122" @default.
- W4297788159 hasPublicationYear "2022" @default.
- W4297788159 type Work @default.
- W4297788159 citedByCount "0" @default.
- W4297788159 crossrefType "journal-article" @default.
- W4297788159 hasAuthorship W4297788159A5008291067 @default.
- W4297788159 hasAuthorship W4297788159A5080187441 @default.
- W4297788159 hasAuthorship W4297788159A5087003916 @default.
- W4297788159 hasBestOaLocation W42977881591 @default.
- W4297788159 hasConcept C178790620 @default.
- W4297788159 hasConcept C181389837 @default.
- W4297788159 hasConcept C185592680 @default.
- W4297788159 hasConcept C2776420369 @default.
- W4297788159 hasConcept C43617362 @default.
- W4297788159 hasConcept C71924100 @default.
- W4297788159 hasConcept C98274493 @default.
- W4297788159 hasConceptScore W4297788159C178790620 @default.
- W4297788159 hasConceptScore W4297788159C181389837 @default.
- W4297788159 hasConceptScore W4297788159C185592680 @default.
- W4297788159 hasConceptScore W4297788159C2776420369 @default.
- W4297788159 hasConceptScore W4297788159C43617362 @default.
- W4297788159 hasConceptScore W4297788159C71924100 @default.
- W4297788159 hasConceptScore W4297788159C98274493 @default.
- W4297788159 hasIssue "2" @default.
- W4297788159 hasLocation W42977881591 @default.
- W4297788159 hasOpenAccess W4297788159 @default.
- W4297788159 hasPrimaryLocation W42977881591 @default.
- W4297788159 hasRelatedWork W2004325424 @default.
- W4297788159 hasRelatedWork W2073311134 @default.
- W4297788159 hasRelatedWork W2080955156 @default.
- W4297788159 hasRelatedWork W2100880117 @default.
- W4297788159 hasRelatedWork W2146516427 @default.
- W4297788159 hasRelatedWork W2400119402 @default.
- W4297788159 hasRelatedWork W2546643235 @default.
- W4297788159 hasRelatedWork W3109196503 @default.
- W4297788159 hasRelatedWork W3178612228 @default.
- W4297788159 hasRelatedWork W3195625925 @default.
- W4297788159 hasVolume "2" @default.
- W4297788159 isParatext "false" @default.
- W4297788159 isRetracted "false" @default.
- W4297788159 workType "article" @default.